|1.||Yao, Zemin: 3 articles (01/2013 - 08/2002)|
|2.||Zaidi, Nousheen: 2 articles (04/2015 - 01/2014)|
|3.||Romeo, Stefano: 2 articles (02/2015 - 01/2015)|
|4.||Borén, Jan: 2 articles (02/2015 - 07/2008)|
|5.||Valenti, Luca: 2 articles (02/2015 - 01/2015)|
|6.||Dongiovanni, Paola: 2 articles (02/2015 - 01/2015)|
|7.||Llorente-Cortés, Vicenta: 2 articles (10/2014 - 05/2011)|
|8.||Badimon, Lina: 2 articles (10/2014 - 05/2011)|
|9.||Rader, Daniel J: 2 articles (03/2014 - 02/2009)|
|10.||Kovanen, Petri T: 2 articles (05/2013 - 10/2006)|
07/15/2010 - "VLDLs (very-low-density lipoproteins) are synthesized in the liver and play an important role in the pathogenesis of atherosclerosis. "
02/01/1998 - "Combined hyperlipidaemia, a frequent form of dyslipidaemia which is associated with premature atherosclerosis, is characterized by elevated plasma concentrations of both triglyceride-rich, very-low-density lipoproteins (VLDL) and LDL. "
12/30/1992 - "To explore the role of LPL in atherogenesis, the effect of LPL-mediated lipolysis of very low density lipoproteins (VLDL) on monocyte adhesion to endothelial cells was examined. "
08/01/1992 - "[Do very low density lipoproteins (VLDL) participate in atherogenesis?]."
01/01/1985 - "Very low density lipoproteins in type II diabetes mellitus and risk of atherosclerosis."
06/01/1971 - "A biochemical and morphologic study of very low density lipoproteins in carbohydrate-induced hypertriglyceridemia."
01/01/2009 - "Hypertriglyceridemia in Watanabe heritable hyperlipidemic rabbits was associated with increased production and reduced catabolism of very-low-density lipoproteins."
04/01/2006 - "Hypertriglyceridemia (40- to 70-fold rise of controls) was found in the acute phase of the disease in the affected ponies, and was derived from increased very-low density lipoproteins. "
07/01/1993 - "All healthy lipemic MS and diabetic lipemic MS had hypertriglyceridemia associated with excess very low density lipoproteins. "
10/01/1992 - "These two abnormalities are, however, rare, and the majority of hypertriglyceridemias are, in practice, associated with increased very low density lipoproteins. "
|3.||Coronary Disease (Coronary Heart Disease)
01/01/2011 - "[Investigation of peroxide modification of low- and very low-density lipoproteins in patients with coronary heart disease by the method of fluorescent spectroscopy]."
03/01/1999 - "The determination of the atomic structure of the MTP-PDI heterodimer has important implications for the treatment of those forms of hyperlipidaemia associated with the overproduction of very-low-density lipoproteins, which predispose to premature coronary heart disease. "
05/01/1979 - "Beta- and pre-beta-lipoproteins in coronary disease and hyperlipoproteinaemia."
07/01/1997 - "Primary and secondary prevention studies including the Coronary Primary Prevention Trial, Helsinki Heart Study, and the Coronary Drug Project have shown that lowering the atherogenic low density lipoproteins (LDL) and very low density lipoproteins (VLDL) whilst raising the high density lipoproteins (HDL) significantly decreases the risk for coronary disease. "
07/06/1998 - "In patients with coronary disease, angiographic progression and clinical events have been correlated with concentrations of smaller very-low-density lipoproteins (VLDL) and intermediate-density lipoproteins (IDL), consistent with evidence for enhanced atherogenicity of lipolytic products of triglyceride-rich lipoprotein metabolism, including postprandial lipoproteins. "
|4.||Coronary Artery Disease (Coronary Atherosclerosis)
01/04/1993 - "Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease."
07/11/1987 - "Changes in serum mass concentrations of low-density lipoproteins (LDL; flotation rate 0-12), very-low-density lipoproteins (VLDL; flotation rate 20-400), high-density lipoproteins (HDL), and the HDL2 and HDL3 subfractions did not differ significantly between men with and without definite progression of coronary artery disease. "
01/01/2004 - "Serum total lipids (cholesterol and triglyceride), lipoproteins (VLDL, LDL and HDL) and Apolipoprotein-B levels of normal healthy individuals (n=25) and coronary artery disease patients (n=25) were estimated. "
01/01/2003 - "Plasma elevation of low-density lipoprotein cholesterol (LDL-C), very low-density lipoproteins (VLDL) and lipoprotein(a), and reduced levels of high-density lipoproteins (HDL-C) are risk factors for coronary artery disease. "
12/01/1998 - "Patients with coronary artery disease and microalbuminuria had higher triglycerides, beta, pre beta lipoproteins, Apo B, Lp(a) and lower Apo B and alpha lipoproteins. "
03/01/1995 - "To study the mechanism of dyslipoproteinemia, lipoproteins [very low density lipoprotein (VLDL), low density lipoprotein (LDL) and high density lipoprotein (HDL)] were isolated from stroke patients and healthy persons by ultracentrifugation. "
11/01/1986 - "Serum cholesterol, low density lipoproteins (LDL), very low density lipoproteins (VLDL) and chylomicron levels were studied in 25 young patients (age 40 years or less) of non-embolic ischemic stroke of unknown aetiology. "
01/01/2011 - "There were increased concentrations of total cholesterol, triglycerides (p<0.001), and atherogenic lipoproteins: VLDL (p<0.001), total LDL, LDL2 (p<0.0001) and LDL3-7 (p<0.01), in the group of stroke patients, compared to the control group. "
01/01/2006 - "Statins inhibit cholesterol synthesis and are effective in lowering total cholesterol levels in plasma or serum due to reductions in low-density lipoprotein and very low-density lipoproteins, as well as reducing progression of coronary atherosclerosis, coronary heart disease, and stroke morbidity and mortality. "
|4.||Apolipoproteins B (ApoB)
|7.||Bile Acids and Salts (Bile Acids)
|9.||LDL Lipoproteins (beta Lipoproteins)
|4.||Renal Dialysis (Hemodialysis)
|5.||Drug Therapy (Chemotherapy)